Integrated Glycoproteomics Identifies Dynamic IgA1 N‐Glycosylation and FUT8 as a Functional Mediator in Multiple Myeloma
Hematological Oncology · 2026
DOI: 10.1002/hon.70216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2026. Verfasst von Xu Si und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Fucosyltransferases, Proteomics, Immunoglobulin A. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, Beijing Municipal Administration of Hospitals.
Abstract (Originalsprache)
Aberrant protein glycosylation is pivotal in cancer progression. However, the IgA glycosylation landscape in multiple myeloma (MM) and its regulatory mechanisms remain uncharacterized. We conducted a comprehensive glycoproteomic analysis of site‐specific N‐glycosylation at IgA1‐Asn144 across a large cohort, including newly diagnosed MM patients ( n = 50), healthy controls ( n = 38), and longitudinal samples from various remission stages. Analysis was performed using Zeno trap‐equipped time‐of‐flight mass spectrometry. We identified a significant upregulation of fucosylated N‐glycopeptides in MM. A diagnostic model based on two fucosylated glycopeptides showed potential diagnostic utility (AUC = 0.808). Attaining deep therapeutic remission was associated with a marked loss of fucosylation and downregulation of hypersialylated glycans. Bioinformatics analysis pinpointed the fucosyltransferase FUT8 as a key differentially expressed regulator, which was subsequently validated to be elevated in MM at both RNA and protein levels. FUT8 promotes tumor progression by activating Wnt/β‐catenin signaling and EMT‐associated pathways, thereby enhancing MM cell proliferation, migration, and invasiveness. These findings identify FUT8 as a potential prognostic biomarker and a therapeutic target in MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
- Department of Clinical Laboratory, Civil Aviation General Hospital, Beijing, China.
Förderung
- Beijing Municipal Natural Science Foundation
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
- Beijing Municipal Administration of Hospitals
Zitieren
APA
Si, X., Zhao, R., Song, Y., Fu, W., Zhao, J., Gong, Y., & Zhang, R. (2026). Integrated Glycoproteomics Identifies Dynamic IgA1 N‐Glycosylation and FUT8 as a Functional Mediator in Multiple Myeloma. Hematological Oncology. https://doi.org/10.1002/hon.70216
Vancouver
Si X, Zhao R, Song Y, Fu W, Zhao J, Gong Y, et al. Integrated Glycoproteomics Identifies Dynamic IgA1 N‐Glycosylation and FUT8 as a Functional Mediator in Multiple Myeloma. Hematological Oncology. 2026. doi:10.1002/hon.70216
BibTeX
@article{Si2026,
author = {Si, Xu and Zhao, Rui and Song, Yichuan and Fu, Wenxuan and Zhao, Jing and Gong, Yahan and Zhang, Rui},
title = {Integrated Glycoproteomics Identifies Dynamic IgA1 N‐Glycosylation and FUT8 as a Functional Mediator in Multiple Myeloma},
journal = {Hematological Oncology},
year = {2026},
doi = {10.1002/hon.70216}
}
EUVIMED